Regional Medical Imaging

What Regional Medical Imaging does

Regional Medical Imaging (RMI) is the largest outpatient diagnostic imaging organization in Michigan, operating 11 locations spanning Mid-Michigan, Southeast Michigan, and Northern Michigan, and employing 101-250 staff including 18 fellowship-trained radiologists. Founded in 1985 by Dr. David Strahle and currently led by CEO/Owner Dr. Randy D. Hicks, MD, MBA, and Co-CEO Carrie Berlin, RMI delivers the full spectrum of diagnostic and interventional imaging — MRI (including 4D breast MRI, rapid screening breast MRI, and multi-parametric prostate MRI), CT (diagnostic, cardiac calcium scoring, coronary CT angiography, low-dose lung screening), PET/CT, 3D mammography (UltimateMamm), contrast-enhanced spectral mammography, ultrasound, X-ray, nuclear medicine, bone densitometry, whole-body MRI, and image-guided interventional procedures including pain management and biopsies. RMI holds American College of Radiology accreditations in all 22 diagnostic imaging categories — a distinction no other Michigan outpatient imaging center has achieved — and is the first private radiology facility in Michigan designated as an ACR Breast Imaging Center of Excellence, with two locations also designated ACR Prostate Cancer MRI Centers.

RMI's core technology platform combines multi-modality imaging hardware, the Abbadox-powered patient portal for image/report access, CareSelect Clinical Decision Support integration for referring physicians, and a March 2025 AI integration across MRI, CT, and mammography workflows. The company runs a distinct clinical trial imaging business unit serving named pharmaceutical sponsors (Eli Lilly, Pfizer, Bayer, Arcturus) and CROs (Onyx Clinical Research, TopoHealth, Prism, Retina Clinical Research) with protocol-perfect imaging delivered to study specifications. RMI also offers BRCA genetic testing and community-facing programs including free mammograms for uninsured patients.

The business model is primarily fee-for-service: RMI bills transactionally per imaging exam to a long tail of insurance carriers (most major plans accepted) and directly to self-pay patients via published cash pricing positioned at least 50% below hospital-based competitors. A secondary professional services revenue stream comes from per-study contracts with pharmaceutical sponsors and CROs for clinical trial imaging. Distribution is hybrid: individual patients self-schedule via the patient portal or are referred by physicians across Michigan, while enterprise clinical trial contracts are sourced through direct relationships with a dedicated Clinical Trial Imaging Lead. Brand-building is anchored on community sponsorship (Back to the Bricks, ACS Making Strides, Crim Fitness Foundation, Food Bank of Eastern Michigan, United Cancer Alliance) and content marketing across blog and social channels.

Name

Regional Medical Imaging

Legal name

Regional Medical Imaging

Website

https://rmipc.net

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

101–250 employees

Short description

Regional Medical Imaging is Michigan's largest outpatient diagnostic imaging organization, operating 11 locations with 18 fellowship-trained radiologists, offering MRI, CT, PET/CT, mammography, and interventional services to individual patients, referring physicians, and pharmaceutical clinical trial sponsors.

Ownership category

akta.pro rank

Product category

Outpatient Diagnostic Medical Imaging

NAICS

Diagnostic Imaging Centers (621512), Offices of Physicians (62111)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN)

akta.pro secondary industries

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB), Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound) (HLAFAKAA), Breast Imaging Centers (Mammography/Tomosynthesis) (HLAFAKAD), Women’s Imaging & Breast Health Centers (HLAFAJAJ), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)

Keywords

• Outpatient diagnostic imaging
• Medical imaging services
• Radiology center network
• Women's imaging services
• Clinical trial imaging

Headquarters

HQ city

Flint

HQ country

United States

HQ region

North America

Offices11 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Diagnostic Imaging Services: RMI generates revenue through fee-for-service billing for diagnostic and preventive imaging examinations. Services are billed to insurance (most major insurance plans accepted) and/or directly to patients via cash pay. The company offers transparent cash pricing for uninsured or under-insured patients, positioned at significant discount to hospital-based imaging.
2. Clinical Trial Imaging Services: RMI provides precision imaging for pharmaceutical clinical trials under contract with sponsors, CROs, and research sites. Revenue is generated through per-study contracts with pharmaceutical companies and research organizations, with imaging performed to precise study protocol specifications.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Regional Medical Imaging provides outpatient diagnostic and preventive medical imaging services across 10–11 Michigan locations, offering MRI, CT, PET/CT, 3D mammography, ultrasound, X-ray, nuclear medicine, bone densitometry, interventional radiology, and genetic testing (BRCA). The company generates revenue through fee-for-service imaging billed to insurance or via published cash-pay prices (50%+ below hospital-based competitors), and also contracts with pharmaceutical sponsors and CROs for protocol-perfect clinical trial imaging.

Product overview

Regional Medical Imaging (RMI) operates as Michigan's largest outpatient imaging organization with 10 locations, offering a comprehensive diagnostic and interventional imaging portfolio. The core offering centers on advanced imaging modalities including MRI (full-body, prostate, breast including 4D and rapid screening), CT (diagnostic, cardiac calcium scoring, coronary angiography, lung cancer screening), PET/CT, mammography (3D UltimateMamm with tomosynthesis, contrast-enhanced mammography), ultrasound, X-ray, nuclear medicine, bone densitometry, and image-guided biopsies. RMI provides specialized interventional radiology services including pain management and vascular access. The organization offers genetic testing (BRCA), clinical trial imaging services for pharmaceutical research, and a patient portal for digital image access. RMI holds multiple American College of Radiology designations including Breast Imaging Center of Excellence and Prostate Cancer MRI Center accreditations. The company has recently integrated AI technology for enhanced diagnostic accuracy.

Differentiator

Problem solved

Functional benefit

Brands

• UltimateMamm: A comprehensive 3D mammography screening service offered exclusively at RMI that provides breast density assessment, Tyrer-Cuzick lifetime cancer risk scoring, and HBOC hereditary risk evaluation.
• Rapid Screening Breast MRI
• RMI Clinical Trial Imaging

Products and services

• 3D Mammography (UltimateMamm) 3D digital breast tomosynthesis mammography offering layered imaging for early breast cancer detection, particularly beneficial for women with dense breast tissue. RMI's branded UltimateMamm includes breast density assessment, Tyrer-Cuzick lifetime cancer risk scoring, and HBOC hereditary risk evaluation.
• 4D Breast MRI Advanced magnetic resonance imaging for detailed breast tissue examination using 4D imaging, providing comprehensive diagnostic capabilities for breast health assessment. First 4D breast MRI service in Michigan.
• Rapid Screening Breast MRI Streamlined 10–15 minute breast MRI screening exam using contrast dye for high-quality imaging without radiation exposure, designed for supplemental screening of women with dense breast tissue or intermediate breast cancer risk.
• Contrast-Enhanced Mammography (CEM) Diagnostic breast imaging using iodinated contrast injection to provide clearer images of breast tissue for determining cancer characteristics, particularly useful for high-risk patients or those with dense breasts.
• Image-Guided Breast Biopsy Minimally invasive biopsy procedures using imaging guidance for accurate tissue sampling and diagnosis of breast abnormalities.
• BRCA Gene Testing Genetic testing for BRCA1 and BRCA2 gene mutations to assess breast cancer risk and guide preventive care decisions. First BRCA gene testing service offered in Michigan.
• Computed Tomography (CT) X-ray-based cross-sectional imaging for detailed views of organs, bones, blood vessels, and tissues throughout the body.
• Cardiac CT Calcium Score Low-dose CT scan measuring calcified plaque in coronary arteries to estimate heart disease risk using the Agatston scoring method.
• Coronary CT Angiography CT imaging of coronary arteries to detect blockages and evaluate heart function and blood flow.
• CT Lung Cancer Screening Low-dose CT screening for lung cancer detection in high-risk individuals, using approximately one-fifth the radiation of standard diagnostic CT. Covered by insurance for eligible patients meeting USPSTF criteria.
• MRI Magnetic resonance imaging using powerful magnets and radio waves to create detailed body images without radiation exposure.
• Prostate MRI Multi-parametric prostate MRI for advanced prostate cancer screening and diagnosis, helping men avoid unnecessary biopsies. RMI's Flint (Lennon Road) and Novi locations hold ACR Prostate Cancer MRI Center designations (among only three in Michigan).
• Whole-Body MRI Comprehensive MRI scan imaging all major organs, tissues, and blood vessels from brain to pelvis with no radiation exposure, used for preventive health monitoring.
• Bone Densitometry / DEXA Bone density scanning to diagnose osteoporosis and assess fracture risk using low-dose X-ray technology.
• Nuclear Medicine Molecular imaging using radioactive tracers to evaluate organ function and detect disease at the cellular level.
• PET/CT Combined PET and CT imaging showing both body structure and cellular function for comprehensive diagnostic evaluation, offered at RMI's Advanced Imaging Center.
• Ultrasound Sound wave-based imaging for various diagnostic applications without radiation exposure.
• X-Ray / Fluoroscopy Traditional X-ray imaging and real-time fluoroscopy for bone, chest, and various diagnostic examinations. Walk-in X-rays available at select locations.
• Interventional Radiology Minimally invasive, image-guided treatments performed by fellowship-trained radiologists including biopsies, drainages, and therapeutic procedures.
• Interventional Pain Management Minimally invasive pain management services including back pain treatment and kyphoplasty to help patients with chronic pain.
• Vascular Access Image-guided vascular access procedures for various medical needs.
• Biopsy, Drainage, Injections Image-guided procedures for tissue sampling, fluid drainage, and therapeutic injections.
• Clinical Trial Imaging Clinical research imaging services for pharmaceutical trials including MRI, CT, PET/CT, ultrasound, and X-ray performed to precise study specifications with certified compliance. Sold under contract to pharmaceutical sponsors and CROs.

Quantifiable outcome

• Early detection improves survival: 99% 5-year survival rate for localized breast cancer caught early; 92% survival rate for lung cancer caught early vs. 15% if caught late.
• +4 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability2 records

Feature7 records

Partnerships

16 partnerships are on record, tiered community, major, core and minor.

• United Cancer Alliance (UCA)communityGTM or Marketing Partner · 1 January 2025501c3 nonprofit assisting cancer patients with rent, utilities, and transportation. RMI sponsors UCA events including the Furniture Raffle (Men's Health Month) and Tee to Green for Men's Health, raising funds and awareness for cancer patient support.
• Crim Fitness FoundationcommunityGTM or Marketing Partner · 1 January 2025RMI sponsored and participated in the ribbon cutting and dedication of the new RMI Crim Community Room at the Crim Fitness Foundation facility, reflecting shared commitment to community health and wellness. Multi-purpose space with state-of-the-art technology and demonstration kitchen.
• American Cancer Society (ACS)communityGTM or Marketing Partner · 1 January 2025RMI participates in ACS Making Strides Against Breast Cancer as a major team. In 2025, RMI's team was second largest out of ~150 teams, raising over $111,000. RMI also attended ACS donor recognition event at Mott Community College.
• Food Bank of Eastern MichigancommunityGTM or Marketing Partner · 1 January 2025RMI was 9:00 AM sponsor at the Feeding Frenzy fundraiser benefiting the Food Bank of Eastern Michigan, supporting the fight against hunger in the communities RMI serves.
• Manna Food ProjectcommunityGTM or Marketing Partner · 1 January 2025RMI (through its Petoskey location) was a Silver Sponsor of the Manna Food Project, a Northern Michigan food insecurity organization where every dollar donated has five times the buying power.
• Crim Fitness FoundationcommunityGTM or Marketing Partner · 1 January 2025RMI sponsored and participated in the ribbon cutting ceremony for the new Flint YMCA, Crim Fitness Foundation, and Hurley Physical Rehabilitation Center — part of Flint's Healthcare Corridor growth.
• Eli LillymajorStrategic or Co-development PartnerPharmaceutical sponsor partner for clinical trial imaging services. RMI provides protocol-perfect imaging for Lilly-sponsored clinical trials, including MRI, CT, PET/CT, ultrasound, and X-ray modalities per study specifications.
• PfizermajorStrategic or Co-development PartnerPharmaceutical sponsor partner for clinical trial imaging. RMI performs imaging to Pfizer's clinical trial protocols as a research imaging provider.
• BayermajorStrategic or Co-development PartnerPharmaceutical sponsor partner for clinical trial imaging services.
• Onyx Clinical ResearchcoreStrategic or Co-development PartnerCRO partner for clinical trial imaging. Onyx Clinical Research has provided a testimonial praising RMI's efficiency and responsiveness: 'I have never worked with a more efficient and incredible facility.' Hind Al khashali, Clinical Research Coordinator.
• ArcturusmajorStrategic or Co-development PartnerPharmaceutical sponsor partner for clinical trial imaging services.
• TopoHealthminorStrategic or Co-development PartnerPartner in clinical trial imaging services.
• Prism (Clinical Research)minorStrategic or Co-development PartnerPartner in clinical trial imaging services.
• Retina Clinical ResearchminorStrategic or Co-development PartnerPartner in clinical trial imaging services.
• New Choice HealthminorChannel Partner/ Reseller/ DistributorRMI participates in New Choice Health's online healthcare pricing comparison platform, listing imaging exam prices alongside competitors. RMI ranks at the top for low prices across imaging categories.
• CareSelect (National Decision Support)coreTechnology or IntegrationRMI provides free connectivity to CareSelect, a web-based Clinical Decision Support tool for referring physicians. CareSelect generates a Decision Support Number (DSN) confirming imaging orders meet AUC criteria — required for Medicare Part B advanced imaging orders under PAMA 2014.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• RadNet: RadNet is the largest U.S. outpatient imaging network with hundreds of centers across multiple states, offering MRI, CT, mammography, and PET/CT. It is the closest scaled analog to RMI's regional multi-modality outpatient model, and competes for similar payer contracts, AI partnerships, and clinical trial business.
• SimonMed Imaging: SimonMed Imaging is one of the largest outpatient imaging providers in the U.S., operating a multi-state network offering MRI, CT, ultrasound, mammography, and specialty imaging. It competes head-to-head with RMI for self-pay and physician-referred patients and shares a focus on price transparency and advanced modalities.
• Akumin: Akumin operates a large network of outpatient imaging centers and recently went private through a Stonepeak-led transaction. It is directly comparable to RMI in modality mix, hospital-alternative positioning, and clinical research imaging services, though at significantly larger scale.
• US Radiology Specialists: US Radiology Specialists is a partnership-model outpatient imaging platform spanning multiple states, offering MRI, CT, mammography, and interventional services. Its multi-specialty, multi-site model is structurally similar to RMI's regional outpatient network approach.
• Center for Diagnostic Imaging (CDI): CDI operates outpatient imaging centers across the U.S. providing MRI, CT, mammography, and other modalities. It is a comparable regional outpatient imaging peer with similar specialty offerings including breast and prostate imaging programs.
• Touchstone Imaging: Touchstone Imaging operates a multi-state outpatient imaging network offering MRI, CT, ultrasound, X-ray, and mammography. It is directly comparable to RMI in service mix and outpatient-only delivery model, though at broader geographic scale.
• Envision Radiology: Envision Radiology is a multi-state outpatient imaging group providing MRI, CT, ultrasound, mammography, and interventional services. Its service mix and outpatient center footprint are directly comparable to RMI's model.

Broad incumbents

• Radiology Partners: Radiology Partners is the largest U.S. radiology physician practice, providing imaging services across hundreds of hospital and outpatient sites. It overlaps RMI's clinical-trial imaging capabilities and radiologist staffing model but operates at substantially larger scale as a broad radiology services incumbent.

Regional players

• Corewell Health: Corewell Health is one of Michigan's largest integrated health systems, operating hospital-based and outpatient imaging across the state. As a regional player, it competes directly with RMI in the same Michigan geography via owned outpatient centers and employed-PCP referral channels.
• Henry Ford Health: Henry Ford Health is a major Michigan-based integrated delivery network with extensive imaging assets across southeast Michigan. It competes with RMI for advanced imaging referrals in overlapping southeast Michigan geographies and uses employed-physician channels to direct patient flow.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCXqFOeLm6GkVMAVJdT6qJYA
• Facebookfacebook.com/rmipc
• LinkedInlinkedin.com/company/regional-medical-imaging
• Xx.com/michiganrmi

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regional Medical Imaging